Array Biopharma, Inc. (ARRY) Didn't Lose as Much as Expected in Q1

October 31, 2013 7:54 AM

Array Biopharma, Inc. (NASDAQ: ARRY) reported Q1 EPS of ($0.13) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found